Helia alata
Helia alata · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Helia alata is a fascinating botanical species that has recently garnered significant scientific interest due to its unique chemical properties. Research has identified the presence of Irlbacholine within the plant, a compound that holds immense potential for pharmacological applications. Studies indicate that this specific chemical exhibits notable activity against various formidable fungal pathogens. Specifically, it demonstrates effectiveness in addressing conditions caused by Aspergillus fumigatus, Candida albicans, and Cryptococcus neoformans. Consequently, Helia alata represents a promising subject in the ongoing search for novel antifungal agents.
- Synonyms
- Lisianthius Alatus · Lisianthius Campanulaceus · 3 more
- Common names
- Not available
- Family
- Gentianaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Synonyms
Helia alata is a botanical subject characterized by a complex history of taxonomic classifications. Throughout scientific literature, this plant is frequently identified by several established synonyms, including Chelonanthus alatus and Helia campanulacea. Researchers may also encounter it documented under the name Irlbachia alata depending on the specific botanical study. Furthermore, the species has been linked to the genus Lisianthius through the names Lisianthius alatus and Lisianthius campanulaceus. Understanding these various nomenclatural relationships is essential for accurate identification and consistent communication within the botanical community.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Helia alata is a unique member of the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It belongs to the specific genus Helia, which places it in a distinct botanical group. Furthermore, its taxonomic lineage follows the order Gentianales. Finally, this plant is a specialized representative of the Gentianaceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Gentianaceae |
| Genus | Helia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Helia alata maintains an expansive geographic presence that spans across several diverse regions of the tropics. This resilient species is widely distributed throughout Southern America, reaching into the Caribbean and the islands of Trinidad and Tobago. Its range extends northward through Central America, with established populations found in Nicaragua and Panamá. Furthermore, the plant thrives across Northern South America, specifically occupying territories within French Guiana and Guyana. This broad distribution highlights the plant's ability to adapt to various ecological niches across the American continents.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Helia alata is a self-supporting herb that maintains a sturdy, upright structure. This plant typically reaches a maximum height of 1.5 meters as it grows. Its compact form makes it a distinctive feature within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Helia alata is the natural source of irlbacholine, a unique antifungal plant metabolite. This specific bisphosphocholine compound has demonstrated significant potency in inhibiting various fungal pathogens. Research indicates that irlbacholine is particularly effective against species such as Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus. Studies suggest that the molecule's 22-carbon chain length plays a critical role in achieving its optimal biological activity. Consequently, the discovery of this metabolite has paved the way for the synthesis of novel analogues for medicinal use.
Conditions
Irlbachia alata possesses significant medicinal properties, specifically through the metabolite irlbacholine which demonstrates potent antifungal activity. This plant metabolite effectively treats the fungal pathogens Aspergillus fumigatus, Candida albicans, and Cryptococcus neoformans. Beyond its antifungal capabilities, the plant also shows promise in treating malaria. Specifically, extracts from Irlbachia alata have been shown to inhibit the growth of Plasmodium yoelii rodent malaria in vivo. These combined biological activities highlight the diverse therapeutic potential of this species against both fungal and parasitic threats.